ChromaDex Inc.

United States of America

Back to Profile

1-94 of 94 for ChromaDex Inc. Sort by
Query
Aggregations
IP Type
        Trademark 47
        Patent 47
Jurisdiction
        United States 52
        World 23
        Canada 14
        Europe 5
Date
New (last 4 weeks) 1
2025 April (MTD) 1
2024 December 2
2025 (YTD) 1
2024 9
See more
IPC Class
C07H 19/048 - Pyridine radicals 29
A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom 23
C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom 13
A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof 8
A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides 7
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 25
01 - Chemical and biological materials for industrial, scientific and agricultural use 19
42 - Scientific, technological and industrial services, research and design 9
41 - Education, entertainment, sporting and cultural services 8
35 - Advertising and business services 7
See more
Status
Pending 25
Registered / In Force 69

1.

NIAGEN

      
Serial Number 99120020
Status Pending
Filing Date 2025-04-03
Owner CHROMADEX, INC. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Dietary supplements; Nutritional supplements; Dietary supplements for health, cellular energy, cellular health, cellular repair, brain health, muscle health and recovery, immune health, heart health, stress management, and healthy aging; Nutritional supplements for health, cellular energy, cellular health, cellular repair, brain health, muscle health and recovery, immune health, heart health, stress management, and healthy aging

2.

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

      
Application Number 18744419
Status Pending
Filing Date 2024-06-14
First Publication Date 2024-12-19
Owner ChromaDex Inc. (USA)
Inventor
  • Erickson, Aron
  • Redpath, Philip
  • Nkrumah-Elie, Yasmeen Maisha
  • Shao, Andrew Earl

Abstract

A stable intravenous (I.V.) composition includes nicotinamide riboside (NR) as described, or other nicotinyl riboside compounds which are NAD+ precursors, in said intravenous form. NR chloride may be provided in an intravenous (I.V.) formulation for administration to a human subject.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 31/7084 - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide

3.

NICOTINAMIDE RIBOSIDE AND DERIVATIVES THEREOF IN INTRAVENOUS FORMULATIONS AND METHODS OF USE THEREOF

      
Application Number US2024034183
Publication Number 2024/259359
Status In Force
Filing Date 2024-06-14
Publication Date 2024-12-19
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Redpath, Philip
  • Nkrumah-Elie, Yasmeen Maisha
  • Shao, Andrew Earl

Abstract

A stable intravenous (I.V.) composition includes nicotinamide riboside (NR) as described, or other nicotinyl riboside compounds which are NAD+ precursors, in said intravenous form. NR chloride may be provided in an intravenous (I.V.) formulation for administration to a human subject.

IPC Classes  ?

  • A61K 31/395 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
  • A61K 9/00 - Medicinal preparations characterised by special physical form

4.

NIAGEN

      
Serial Number 98788240
Status Pending
Filing Date 2024-10-07
Owner CHROMADEX, INC. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Chemical ingredients for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals, cosmetics, cosmetic preparations, pet products, and personal care products; chemical reagents for non-medical purposes; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use; test kits comprised of preparations and reagents for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes for non-medical purposes; test kits comprised of agents and preparations for non-medical purposes; specimen collection kits for non-medical purposes comprised of swabs, test strips, plastic bags for transmitting specimens, printed mailing labels, and tubes for holding specimens; test kits for testing for markers in bodily fluids, liquids, saliva and tissue for non-medical purposes; preparations and articles for the testing of nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging for non-medical purposes Pharmaceutical preparations, namely, nicotinamide riboside chloride for injection; pharmaceutical preparations, namely, injectable liquids for use in hydration, vitamin, healthy aging, and wellness therapies; pharmaceutical preparations, namely, injectable liquids for increasing health, healthy aging, cellular health, cellular repair, energy, heart health, and muscle health; nicotinamide riboside chloride in the form of injectables; nicotinamide riboside chloride for use in intravenous therapy; diagnostic kits for testing for biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes; diagnostic kits for testing biomarkers and levels of nicotinamide adenine dinucleotide, vitamins, metabolites, and enzymes; diagnostic kits comprising diagnostic agents and preparations for medical purposes; specimen collection kits for medical purposes comprised of swabs, test strips, plastic bags for transmitting medical specimens, printed mailing labels, and tubes for holding specimens; medical test kits for testing for markers in bodily fluids, liquids, saliva and tissue; diagnostic agents, preparations and substances for medical purposes; medical and veterinary preparations and articles for the testing of nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; medical and veterinary preparations and articles for promoting nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; prefilled syringes and injectors filled with pharmaceutical preparations; prefilled syringes and injectors filled with pharmaceutical preparations for promoting nicotinamide adenine dinucleotide levels, cellular energy, brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging; prefilled syringes and injectors filled with nicotinamide riboside chloride; nutritional supplements in the form of injection shot; nicotinamide riboside chloride in the form of injection shot

5.

TRU NIAGEN

      
Serial Number 98666266
Status Pending
Filing Date 2024-07-25
Owner CHROMADEX, INC. ()
NICE Classes  ? 35 - Advertising and business services

Goods & Services

On-line retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, non-medicated toiletry preparations, pet products, personal care products, food, and beverages; Retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, non-medicated toiletry preparations, pet products, personal care products, food, and beverages

6.

TRU NIAGEN

      
Serial Number 98663151
Status Pending
Filing Date 2024-07-23
Owner CHROMADEX, INC. ()
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; non-medicated soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish

7.

NIAGEN NANOCLOUD

      
Serial Number 98644474
Status Pending
Filing Date 2024-07-11
Owner CHROMADEX, INC. ()
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; non-medicated soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals

8.

NANOCLOUD

      
Serial Number 98644492
Status Pending
Filing Date 2024-07-11
Owner CHROMADEX, INC. ()
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; non-medicated soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals

9.

NIAGEN

      
Application Number 232305200
Status Pending
Filing Date 2024-04-23
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; cosmetic soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish.

10.

NIAGEN

      
Serial Number 98482923
Status Pending
Filing Date 2024-04-03
Owner CHROMADEX, INC. ()
NICE Classes  ? 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations

Goods & Services

Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; cosmetic soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish

11.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Application Number 18237503
Grant Number 12195494
Status In Force
Filing Date 2023-08-24
First Publication Date 2023-12-07
Grant Date 2025-01-14
Owner
  • The Queen's University of Belfast (United Kingdom)
  • ChromaDex Inc. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, and novel crystalline forms thereof.

IPC Classes  ?

  • C07H 19/048 - Pyridine radicals
  • C07D 307/20 - Oxygen atoms
  • C07H 19/20 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

12.

NRIV

      
Serial Number 98272144
Status Pending
Filing Date 2023-11-15
Owner Chromadex, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Pharmaceutical preparations, namely, nicotinamide riboside for injection; pharmaceutical preparations, namely, injectable liquids for use in hydration, vitamin, healthy aging, and wellness therapies; pharmaceutical preparations, namely, injectable liquids for increasing health, healthy aging, cellular health, cellular repair, energy, heart health, and muscle health; nicotinamide riboside in the form of injectables; nicotinamide riboside for use in intravenous therapy; dietary supplements; nutritional supplements On-line retail store services featuring injectable intravenous solutions, dietary supplements, and nutritional supplements; retail store services featuring injectable intravenous solutions, dietary supplements, and nutritional supplements Intravenous therapy services; intravenous therapy services featuring nicotinamide riboside; providing information about health, healthy aging, lifestyle wellness, healthy eating, and nutrition

13.

METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE

      
Document Number 03243904
Status Pending
Filing Date 2023-03-15
Open to Public Date 2023-09-21
Owner CHROMADEX INC. (USA)
Inventor
  • Redpath, Philip
  • Erickson, Aron
  • Roodman, Jacob
  • Nygaard, Richard

Abstract

This disclosure relates to a process for producing Crystalline Beta Nicotinamide Riboside Triacetate Chloride with improved physical property characteristics. A substantially crystalline Beta Nicotinamide Riboside Triacetate Chloride, or a salt, or a solvate thereof is described having a chemical purity of greater than about 90% (w/w) and containing less than about 5000 ppm ethanol.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 19/048 - Pyridine radicals

14.

METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE

      
Application Number US2023015301
Publication Number 2023/177743
Status In Force
Filing Date 2023-03-15
Publication Date 2023-09-21
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Redpath, Philip
  • Roodman, Jacob
  • Nygaard, Richard

Abstract

This disclosure relates to a process for producing Crystalline Beta Nicotinamide Riboside Triacetate Chloride with improved physical property characteristics. A substantially crystalline Beta Nicotinamide Riboside Triacetate Chloride, or a salt, or a solvate thereof is described having a chemical purity of greater than about 90% (w/w) and containing less than about 5000 ppm ethanol.

IPC Classes  ?

  • C07H 19/048 - Pyridine radicals
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 1/00 - Processes for the preparation of sugar derivatives

15.

METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE

      
Application Number 18184456
Status Pending
Filing Date 2023-03-15
First Publication Date 2023-09-21
Owner ChromaDex Inc. (USA)
Inventor
  • Erickson, Aron
  • Redpath, Philip
  • Roodman, Jacob
  • Nygaard, Richard

Abstract

This disclosure relates to a process for producing Crystalline Beta Nicotinamide Riboside Triacetate Chloride with improved physical property characteristics. A substantially crystalline Beta Nicotinamide Riboside Triacetate Chloride, or a salt, or a solvate thereof is described having a chemical purity of greater than about 90% (w/w) and containing less than about 5000 ppm ethanol.

IPC Classes  ?

16.

TRU NAD+

      
Serial Number 98084355
Status Pending
Filing Date 2023-07-13
Owner Chromadex, Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Active chemical ingredients for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals, cosmetics, cosmetic preparations, pet products, and personal care products; Chemical reagents for non-medical purposes; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes; Diagnostic preparations for scientific or research use Cosmetics; cosmetic preparations; non-medicated toiletry preparations; chemicals sold as components of cosmetics and cosmetic preparations; nutritional supplements sold as a component of cosmetics and cosmetic preparations; cosmetic preparations; body and beauty care cosmetics; cosmetic preparations for body care; cosmetic preparations for skin care; cosmetic preparations in the form of scrubs, lotions, oils, serums, toners, moisturizers, creams, gels, powders, aerosols, sprays, emulsions, pomades, and masks; cosmetic suntan preparations; cosmetic soaps; cosmetic preparations for bath and shower; hair care preparations; cosmetics for animals; make-up; make-up preparations; perfume; cologne; nail care preparations; nail polish Dietary and nutritional supplements; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles for the treatment of declining nicotinamide adenine dinucleotide levels and cellular energy, and for the support of brain health, muscle health and recovery, immune health, heart health, cellular energy and repair, stress management, and healthy aging On-line retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, pet products, personal care products, food, and beverages; Retail store services featuring dietary supplements, nutritional supplements, cosmetics, cosmetic preparations, pet products, personal care products, food, and beverages Providing a website and non-downloadable publications in the nature of articles, newsletters, and blog posts in the field of health, fitness, exercise, workouts, wellness, lifestyle, cosmetics, pet products, personal care products, healthy eating, dietary and nutritional supplements, and nutrition; Providing information and reviews about physical fitness, exercise and fitness workouts Medical and scientific research information in the field of health, nutrition, dietary and nutritional supplements, cosmetics, pet products, personal care products, cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding health, nutrition, dietary and nutritional supplements, cosmetics, pet products, personal care products, cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research Providing information about health, lifestyle, wellness, cosmetics, personal care products, pet health and wellness products, healthy eating, dietary and nutritional supplements, and nutrition

17.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT

      
Application Number 18060257
Status Pending
Filing Date 2022-11-30
First Publication Date 2023-06-29
Owner ChromaDex Inc. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abstract

Infant formula compositions and methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 31/51 - Thiamines, e.g. vitamin B1
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A61K 31/4415 - Pyridoxine, i.e.vitamin B6
  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/7064 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
  • A23L 33/19 - Dairy proteins
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/15 - Vitamins
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein

18.

CERP

      
Application Number 018883916
Status Pending
Filing Date 2023-06-05
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific research consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific consulting and research services relating to foods and dietary supplements; Chemical, biochemical, biological and bacteriological research and analysis; Industrial research in the field of chemicals; Pharmaceutical research and development; Testing, inspection, research, or development of dietary supplements, nutritional products, pharmaceuticals, medicine, and cosmetics; Product research and development; Scientific research and development; Scientific research consulting; Medical research; Research and development and consultation related thereto in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, cosmetics, chemicals, chemical standards, and chemical reference materials; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Design and testing for new product development; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff.

19.

Niagen

      
Application Number 018850193
Status Registered
Filing Date 2023-03-17
Registration Date 2023-04-12
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary preparations; medical and veterinary preparations and articles. Downloadable mobile applications for managing and sharing information on one's health, fitness and nutrition; downloadable software in the nature of a mobile application for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring health, wellness and nutrition; computer software for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition. Providing information about fitness, exercise, and workouts; on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition.

20.

CERP

      
Serial Number 97778081
Status Registered
Filing Date 2023-02-02
Registration Date 2024-02-20
Owner Chromadex, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific research consulting in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, and cosmetics; Scientific consulting and research services relating to foods and dietary supplements; Chemical, biochemical, biological and bacteriological research and analysis; Industrial research in the field of chemicals; Pharmaceutical research and development; Testing, inspection, research, or development of dietary supplements, nutritional products, pharmaceuticals, medicine, and cosmetics; Product research and development; Scientific research and development; Scientific research consulting; Medical research; Research and development and consultation related thereto in the field of dietary supplements, nutritional products, pharmaceuticals, health, medicine, aging, immunology, virology, cosmetics, chemicals, chemical standards, and chemical reference materials; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Design and testing for new product development; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff

21.

CHROMADEX STANDARDS

      
Application Number 018786405
Status Registered
Filing Date 2022-10-28
Registration Date 2023-03-07
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis; Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis, namely, certified samples of botanical materials, chemical solids, and liquids in the nature of reagents and synthetic and natural oxides in the form of powders, liquids, pastes and granules.

22.

CHROMADEX STANDARDS

      
Serial Number 97645874
Status Registered
Filing Date 2022-10-24
Registration Date 2023-05-02
Owner Chromadex, Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis, namely, chemical standards and reference materials, other than for medical or veterinary purposes; Standards and reference materials to be used in the calibration of laboratory measuring instruments and used in laboratory research and analysis, namely, certified samples of botanical extracts and chemical solids, and liquids in the nature of reagents for laboratory research and analysis, and synthetic and natural oxides in the form of powders, liquids, pastes and granules for laboratory research and analysis other than for medical or veterinary purposes

23.

ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE AND OTHER NICOTINYL RIBOSIDE COMPOUNDS

      
Document Number 03206155
Status Pending
Filing Date 2022-01-31
Open to Public Date 2022-08-04
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abstract

A process is provided for microencapsulating nicotinamide riboside (NR), and other NR derivatives by using ethyl cellulose which may be polymerized in a particular manner. Further, compositions comprising NR or derivatives thereof microencapsulated in an edible biopolymer are provided.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 19/048 - Pyridine radicals

24.

ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES

      
Application Number 17589422
Status Pending
Filing Date 2022-01-31
First Publication Date 2022-08-04
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abstract

A process is provided for microencapsulating nicotinamide riboside (NR), and other NR derivatives by using ethyl cellulose which may be polymerized in a particular manner. Further, compositions comprising NR or derivatives thereof microencapsulated in an edible biopolymer are provided.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 9/50 - Microcapsules

25.

ETHYL CELLULOSE BASED COATINGS FOR MICROENCAPSULATION OF NICOTINAMIDE RIBOSIDE AND OTHER NICOTINYL RIBOSIDE COMPOUNDS

      
Application Number US2022014597
Publication Number 2022/165358
Status In Force
Filing Date 2022-01-31
Publication Date 2022-08-04
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abstract

A process is provided for microencapsulating nicotinamide riboside (NR), and other NR derivatives by using ethyl cellulose which may be polymerized in a particular manner. Further, compositions comprising NR or derivatives thereof microencapsulated in an edible biopolymer are provided.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 47/38 - CelluloseDerivatives thereof
  • A61K 9/50 - Microcapsules
  • A61K 8/11 - Encapsulated compositions
  • C07H 19/048 - Pyridine radicals

26.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Application Number 17551592
Grant Number 11345720
Status In Force
Filing Date 2021-12-15
First Publication Date 2022-04-07
Grant Date 2022-05-31
Owner
  • The Queen's University of Belfast (United Kingdom)
  • ChromaDex Inc. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

IPC Classes  ?

  • C07H 19/207 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine-adenine dinucleotide or nicotinamide-adenine dinucleotide
  • C07H 19/048 - Pyridine radicals
  • C07D 307/20 - Oxygen atoms
  • C07H 19/20 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

27.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Application Number 17323789
Grant Number 11242364
Status In Force
Filing Date 2021-05-18
First Publication Date 2022-02-08
Grant Date 2022-02-08
Owner
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (United Kingdom)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof, and novel crystalline forms thereof.

IPC Classes  ?

  • C07H 19/048 - Pyridine radicals
  • C07D 307/20 - Oxygen atoms
  • C07H 19/20 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

28.

TRU NIAGEN

      
Serial Number 97248213
Status Pending
Filing Date 2022-02-01
Owner ChromaDex, Inc. ()
NICE Classes  ? 30 - Basic staples, tea, coffee, baked goods and confectionery

Goods & Services

Sweets; ice cream; ice cream mixes; ice cream desserts; ice cream substitute; frozen dessert, namely, frozen confections and frozen dessert consisting of cream or cream substitutes; ice cream, cream, and cream-substitute based desserts, edible ices, and ice creams with chocolate, fruit, or tea flavoring; ice cream, cream, and cream-substitute based desserts, edible ices, and ice creams containing dietary and nutritional supplements

29.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Application Number 17246090
Grant Number 11274117
Status In Force
Filing Date 2021-04-30
First Publication Date 2021-11-25
Grant Date 2022-03-15
Owner
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (United Kingdom)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

IPC Classes  ?

  • A01N 43/04 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • C07H 19/048 - Pyridine radicals
  • C07D 307/20 - Oxygen atoms
  • C07H 19/20 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

30.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Application Number 16908416
Grant Number 11746123
Status In Force
Filing Date 2020-06-22
First Publication Date 2021-11-11
Grant Date 2023-09-05
Owner
  • The Queen's University of Belfast (United Kingdom)
  • ChromaDex Inc. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

IPC Classes  ?

  • C07H 19/048 - Pyridine radicals
  • C07D 307/20 - Oxygen atoms
  • C07H 19/20 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

31.

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

      
Application Number 17114864
Grant Number 11524022
Status In Force
Filing Date 2020-12-08
First Publication Date 2021-07-29
Grant Date 2022-12-13
Owner ChromaDex Inc. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abstract

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 31/51 - Thiamines, e.g. vitamin B1
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A61K 31/4415 - Pyridoxine, i.e.vitamin B6
  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A61K 31/7064 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
  • A23L 33/19 - Dairy proteins
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/15 - Vitamins
  • A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

32.

SUPERCHARGE YOUR CELLS

      
Serial Number 90806573
Status Pending
Filing Date 2021-07-01
Owner ChromaDex, Inc. ()
NICE Classes  ? 35 - Advertising and business services

Goods & Services

On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

33.

AGE BETTER

      
Application Number 1583567
Status Registered
Filing Date 2021-02-09
Registration Date 2021-02-09
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Nutraceuticals for use as a dietary supplement; vitamin and mineral supplements; vitamins.

34.

AboutNAD

      
Application Number 1584241
Status Registered
Filing Date 2020-11-21
Registration Date 2020-11-21
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Providing educational information in the field of clinical research via a website. Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; providing scientific research information in the field of clinical studies.

35.

SUPERCHARGED BY TRU NIAGEN

      
Serial Number 90609075
Status Pending
Filing Date 2021-03-29
Owner ChromaDex, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services

Goods & Services

Dietary and nutritional supplements On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

36.

CHROMADEX

      
Application Number 018349075
Status Registered
Filing Date 2020-12-04
Registration Date 2022-09-16
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Diagnostic test kits, other than for veterinary purposes; diagnostic preparations, agents, and substances for humans; dietary supplements for humans; nutritional supplements for humans; vitamins for humans; dietary supplement drink mix for humans; nutritional supplement drink mix for humans.

37.

ABOUTNAD

      
Serial Number 90333539
Status Registered
Filing Date 2020-11-20
Registration Date 2021-08-03
Owner ChromaDex, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research

38.

ADDING HEALTH TO YEARS

      
Serial Number 90303248
Status Registered
Filing Date 2020-11-06
Registration Date 2022-06-21
Owner ChromaDex, Inc. ()
NICE Classes  ?
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 35 - Advertising and business services

Goods & Services

Dietary and nutritional supplements On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

39.

Nicotinamide riboside compositions for topical use in treating skin conditions

      
Application Number 16891824
Grant Number 11033568
Status In Force
Filing Date 2020-06-03
First Publication Date 2020-09-17
Grant Date 2021-06-15
Owner ChromaDex Inc. (USA)
Inventor
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abstract

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom

40.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS

      
Document Number 03130704
Status Pending
Filing Date 2020-02-21
Open to Public Date 2020-08-27
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Storjohann, Amanda
  • Redpath, Philip
  • Roberts, Matthew

Abstract

Methods for stabilizing or encapsulating at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), nicotinamide mononucleotide (NMN), nicotinic acid mononucleotide (NaMN), derivatives thereof, or salts thereof, are provided. Compositions including wax prills, stabilized, or encapsulated forms of at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, are also provided.

IPC Classes  ?

  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom
  • C07H 19/048 - Pyridine radicals

41.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS

      
Application Number 16798207
Status Pending
Filing Date 2020-02-21
First Publication Date 2020-08-27
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Storjohann, Amanda
  • Redpath, Philip
  • Roberts, Matthew

Abstract

Methods for stabilizing or encapsulating at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), nicotinamide mononucleotide (NMN), nicotinic acid mononucleotide (NaMN), derivatives thereof, or salts thereof, are provided. Compositions including wax prills, stabilized, or encapsulated forms of at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, are also provided.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 9/00 - Medicinal preparations characterised by special physical form
  • A61K 47/44 - Oils, fats or waxes according to two or more groups of Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
  • A61K 9/14 - Particulate form, e.g. powders
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

42.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, REDUCED NICOTINYL RIBOSIDE COMPOUNDS, AND NICOTINYL RIBOSIDE COMPOUND DERIVATIVES IN FORMULATIONS

      
Application Number US2020019361
Publication Number 2020/172629
Status In Force
Filing Date 2020-02-21
Publication Date 2020-08-27
Owner CHROMADEX INC. (USA)
Inventor
  • Erickson, Aron
  • Storjohann, Amanda
  • Redpath, Philip
  • Roberts, Matthew

Abstract

Methods for stabilizing or encapsulating at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), nicotinamide mononucleotide (NMN), nicotinic acid mononucleotide (NaMN), derivatives thereof, or salts thereof, are provided. Compositions including wax prills, stabilized, or encapsulated forms of at least one compound selected from the group consisting of nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, are also provided.

IPC Classes  ?

  • C07H 19/048 - Pyridine radicals
  • A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

43.

CRYSTALLINE FORMS OF NICOTINOYL RIBOSIDES AND DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF

      
Document Number 03122527
Status Pending
Filing Date 2019-12-10
Open to Public Date 2020-06-18
Owner CHROMADEX INC. (USA)
Inventor
  • Rhonemus, Troy
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abstract

The present disclosure provides crystalline Form II of nicotinic acid riboside (NAR) according to formula (I): that is characterized by a powder X-ray diffraction pattern having peaks at 8.5, 15.8, 16.9, 17.7, and 26.6 degrees two theta ± 0.2 degrees two theta, and methods of preparation thereof. In an embodiment, the present disclosure relates to crystalline forms of nicotinoyl ribosides, derivatives thereof, or salts, hydrates, solvates, or prodrugs thereof. In another embodiment, the present disclosure relates to synthetic sequences or processes that enable the efficient production of crystalline forms of nicotinoyl ribosides, derivatives thereof, or salts, hydrates, solvates, or prodrugs thereof.

IPC Classes  ?

44.

CRYSTALLINE FORMS OF NICOTINOYL RIBOSIDES AND DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF

      
Application Number US2019065456
Publication Number 2020/123488
Status In Force
Filing Date 2019-12-10
Publication Date 2020-06-18
Owner CHROMADEX INC. (USA)
Inventor
  • Rhonemus, Troy
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abstract

The present disclosure provides crystalline Form II of nicotinic acid riboside, crystalline Form II of nicotinic acid riboside triacetate, and methods of preparation thereof. In an embodiment, the present disclosure relates to crystalline forms of nicotinoyl ribosides, derivatives thereof, or salts, hydrates, solvates, or prodrugs thereof. In another embodiment, the present disclosure relates to synthetic sequences or processes that enable the efficient production of crystalline forms of nicotinoyl ribosides, derivatives thereof, or salts, hydrates, solvates, or prodrugs thereof.

IPC Classes  ?

  • A61K 31/443 - Non-condensed pyridinesHydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • C07D 307/20 - Oxygen atoms
  • C07H 19/048 - Pyridine radicals

45.

Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof

      
Application Number 16709060
Grant Number 11214589
Status In Force
Filing Date 2019-12-10
First Publication Date 2020-06-11
Grant Date 2022-01-04
Owner ChromaDex Inc. (USA)
Inventor
  • Rhonemus, Troy
  • Erickson, Aron
  • Storjohann, Amanda
  • Holloway, Joshua
  • Redpath, Philip

Abstract

The present disclosure provides crystalline Form II of nicotinic acid riboside, crystalline Form II of nicotinic acid riboside triacetate, and methods of preparation thereof.

IPC Classes  ?

  • A01N 43/04 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • C07H 19/048 - Pyridine radicals

46.

ABOUTNAD

      
Serial Number 88929471
Status Registered
Filing Date 2020-05-22
Registration Date 2020-11-24
Owner ChromaDex, Inc. ()
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

Medical and scientific research information in the field of cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific information in the field of research regarding cellular energy, nicotinamide adenine dinucleotide, and nicotinamide riboside; Providing scientific research information in the field of clinical studies; Providing a website featuring educational information in the field of clinical research

47.

TRU BELIEVER

      
Serial Number 88897727
Status Registered
Filing Date 2020-05-01
Registration Date 2023-03-28
Owner ChromaDex, Inc. ()
NICE Classes  ? 35 - Advertising and business services

Goods & Services

On-line retail store services featuring dietary and nutritional supplements; Retail store services featuring dietary and nutritional supplements

48.

Miscellaneous Design

      
Serial Number 88424739
Status Registered
Filing Date 2019-05-10
Registration Date 2023-10-10
Owner ChromaDex, Inc. ()
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Providing information about fitness, exercise, and workouts; On-line journals, namely, blogs featuring articles, information, in the field of health, fitness, exercise, workouts, wellness, lifestyle, and nutrition Providing information about health, lifestyle wellness, and nutrition

49.

B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

      
Application Number 15977851
Grant Number 10934322
Status In Force
Filing Date 2018-05-11
First Publication Date 2018-09-13
Grant Date 2021-03-02
Owner
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (United Kingdom)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abstract

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

IPC Classes  ?

  • C07H 19/00 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radicalNucleosidesMononucleotidesAnhydro derivatives thereof
  • C07H 19/048 - Pyridine radicals
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

50.

NIAGEN

      
Application Number 1415549
Status Registered
Filing Date 2018-03-08
Registration Date 2018-03-08
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; chemical reagents for non-medical purposes; chemical test kits, comprised of chemical reagents, for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use and for health assessment. Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles; nutritional supplements. Downloadable mobile applications for managing and sharing information on one's health, fitness and nutrition; downloadable software in the nature of a mobile application for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring health, wellness and nutrition; computer software for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition. Providing information about fitness, exercise, and workouts; on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition.

51.

NIAGEN

      
Application Number 1403232
Status Registered
Filing Date 2018-02-14
Registration Date 2018-02-14
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles; nutritional supplements; dietary and nutritional supplements.

52.

SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NIC OTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF

      
Document Number 03045876
Status Pending
Filing Date 2017-11-10
Open to Public Date 2018-05-17
Owner
  • THE QUEEN'S UNIVERSITY OF BELFAST (United Kingdom)
  • CHROMADEX INC. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides a crystalline Form I of nicotinic acid riboside (NAR) according to a formula (VIII), that may be prepared by a method comprising, dissolving the compound having formula (VIII), or a salt or solvate thereof, in a volume of methanol, adding a volume of acetone, of an equal volume to the volume of methanol, to the compound having formula (VIII), or salt or solvate thereof, in the volume of methanol, precipitating the crystalline Form I, and isolating the crystalline Form I. The present disclosure further provides a crystalline Form I of nicotinic acid riboside triacetate (NARTA) according to a formula (X), that may be prepared by a similar method.

IPC Classes  ?

53.

Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof

      
Application Number 15809731
Grant Number 09975915
Status In Force
Filing Date 2017-11-10
First Publication Date 2018-05-17
Grant Date 2018-05-22
Owner
  • The Queen's University of Belfast (United Kingdom)
  • ChromaDex Inc. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides novel crystalline forms of nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, modified derivatives thereof, and phosphorylated analogs thereof, or salts, solvates, or prodrugs thereof; and methods of preparation thereof.

IPC Classes  ?

  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom
  • C07H 19/048 - Pyridine radicals

54.

Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof

      
Application Number 15809753
Grant Number 10689411
Status In Force
Filing Date 2017-11-10
First Publication Date 2018-05-17
Grant Date 2020-06-23
Owner
  • The Queen's University of Belfast (United Kingdom)
  • ChromaDex Inc. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

IPC Classes  ?

  • C07H 19/207 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine-adenine dinucleotide or nicotinamide-adenine dinucleotide
  • C07H 19/048 - Pyridine radicals
  • C07D 307/20 - Oxygen atoms
  • C07H 19/20 - Purine radicals with the saccharide radical being esterified by phosphoric or polyphosphoric acids
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

55.

EFFICIENT AND SCALABLE SYNTHESES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, MODIFIED DERIVATIVES THEREOF, PHOSPHORYLATED ANALOGS THEREOF, ADENYLYL DINUCLEOTIDE CONJUGATES THEREOF, AND NOVEL CRYSTALLINE FORMS THEREOF

      
Application Number US2017061154
Publication Number 2018/089830
Status In Force
Filing Date 2017-11-10
Publication Date 2018-05-17
Owner
  • THE QUEEN'S UNIVERSITY OF BELFAST (United Kingdom)
  • CHROMADEX INC. (USA)
Inventor
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Erickson, Aron
  • Nygaard, Richard
  • Storjohann, Amanda

Abstract

The present disclosure provides methods of making nicotinoyl riboside compounds or derivatives of formula (I): wherein X", Z 1, Z2, n, R 1, R2, R3, R4, R5, R6,, R7, and R 8 are described herein, reduced analogs thereof, modified derivatives thereof, phosphorylated analogs thereof, and adenylyl dinucleotide conjugates thereof, or salts, solvates, or prodrugs thereof; and novel crystalline forms thereof.

IPC Classes  ?

  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C07H 19/048 - Pyridine radicals

56.

TRU NIAGEN

      
Application Number 1393923
Status Registered
Filing Date 2017-11-21
Registration Date 2017-11-21
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 41 - Education, entertainment, sporting and cultural services

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; chemical reagents for non-medical purposes; chemical test kits, comprised of chemical reagents, for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes; diagnostic preparations for scientific or research use. Dietary and nutritional supplements; diagnostic kits consisting of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes; diagnostic agents, preparations and substances for medical purposes; dietary supplements and preparations; medical and veterinary preparations and articles; nutritional supplements. Downloadable mobile applications for managing and sharing information on one's health, fitness and nutrition; downloadable software in the nature of a mobile application providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring health, wellness and nutrition; computer software for providing information in the fields of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition. Providing information about health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; publication of on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition.

57.

CHROMADEX

      
Serial Number 87753883
Status Registered
Filing Date 2018-01-12
Registration Date 2022-04-26
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals; Chemical reagents for non-medical purposes; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes; Diagnostic preparations for scientific or research use Dietary and nutritional supplements Providing information about fitness, exercise, and workouts; Providing a website featuring on-line journals in the nature of non-downloadable articles in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition; Providing information and reviews about physical fitness, exercise and fitness workouts Providing information about health, lifestyle wellness, healthy eating and nutrition

58.

TRU NIAGEN

      
Application Number 187123700
Status Registered
Filing Date 2017-12-04
Registration Date 2020-09-23
Owner ChromaDex Inc. (USA)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 09 - Scientific and electric apparatus and instruments
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Phytochemical additives for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; chemical reagents for non-medical purposes for use in the dietary and nutritional supplement industry; chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemical additives for use in the manufacture of dietary and nutritional supplements; chemical compositions for use in dietary and nutritional supplements; assays for research purposes for use in the development of dietary and nutritional supplements (2) Dietary and nutritional supplements for general health and well-being (3) Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; diagnostic preparations for medical purposes for improvement of one's general health and wellbeing; diagnostic agents, preparations and substances for medical purposes for improvement of general health and well-being; dietary supplements and preparations for general health and well-being; medical preparations for improvement of general health and well-being and veterinary preparations for improvement of general health and well-being (4) Diagnostic preparations for improvement of general health and well-being (5) Downloadable mobile applications for managing and sharing information on one's general health, fitness and nutrition; downloadable software in the nature of a mobile application providing information in the fields of general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition; downloadable mobile application software for the purpose of tracking and monitoring general health, wellbeing and nutrition; computer software for providing information in the fields of general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition (1) Providing information about general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition; on-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of general health, fitness, exercise, workouts, well-being, personal lifestyle, healthy eating and nutrition

59.

NIAGEN

      
Serial Number 87695359
Status Registered
Filing Date 2017-11-22
Registration Date 2022-03-29
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Chemical reagents for non-medical purposes; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes; Diagnostic preparations for scientific or research use Dietary supplements; Nutritional supplements

60.

USE OF NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE DERIVATIVES, AND REDUCED DERIVATIVES THEREOF, AS NAD+INCREASING PRECURSORS

      
Document Number 03021571
Status In Force
Filing Date 2017-04-20
Open to Public Date 2017-10-26
Grant Date 2023-01-03
Owner CHROMADEX INC. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Erickson, Aron
  • Cassier, Hadi
  • Migaud, Marie E.

Abstract

Compositions are provided including nicotinic acid riboside ("NAR"), and derivatives thereof including l -(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)-nicotinic acid ("NAR triacetate" or "NARTA"); or derivatives of a reduced form of nicotinic acid riboside ("NARH"), including 1 - (2',3',5 '-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid ("NARH triacetate" or "NARJT-TA"); or derivatives of nicotinamide riboside ("NR"), including 1 -(2',3',5'-triacetyl- beta-D-ribofuranosyl)-nicotinamide ("NR triacetate" or "NRTA"); derivatives of a reduced form of nicotinamide riboside ("NRH"), including 1-(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)- 1,4- dihydronicotinamide ("NRH triacetate" or "NRH-TA"); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. Methods of using the compounds above to promote the increase of intracellular levels of nicotinamide adenine dinuc!eotide ("NAD+") or NADH in cells and tissues for improving cell and tissue survival or overall cell and tissue health are provided.

IPC Classes  ?

  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 19/00 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radicalNucleosidesMononucleotidesAnhydro derivatives thereof
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom
  • C07H 19/048 - Pyridine radicals

61.

Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors

      
Application Number 15492952
Grant Number 10183036
Status In Force
Filing Date 2017-04-20
First Publication Date 2017-10-26
Grant Date 2019-01-22
Owner ChromaDex Inc. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Erickson, Aron
  • Casser, Hadi
  • Migaud, Marie Eugenie

Abstract

Compositions are provided including nicotinic acid riboside (“NAR”), and derivatives thereof including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-nicotinic acid (“NAR triacetate” or “NARTA”); or derivatives of a reduced form of nicotinic acid riboside (“NARH”), including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (“NARH triacetate” or “NARH-TA”); or derivatives of nicotinamide riboside (“NR”), including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-nicotinamide (“NR triacetate” or “NRTA”); derivatives of a reduced form of nicotinamide riboside (“NRH”), including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinamide (“NRH triacetate” or “NRH-TA”); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. Methods of using the compounds above to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (“NAD+”) or NADH in cells and tissues for improving cell and tissue survival or overall cell and tissue health are provided.

IPC Classes  ?

  • A01N 43/04 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atom with one hetero atom
  • A61K 31/70 - CarbohydratesSugarsDerivatives thereof
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom

62.

USE OF NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE DERIVATIVES, AND REDUCED DERIVATIVES THEREOF, AS NAD+ INCREASING PRECURSORS

      
Application Number US2017028673
Publication Number 2017/184885
Status In Force
Filing Date 2017-04-20
Publication Date 2017-10-26
Owner CHROMADEX INC. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Erickson, Aron
  • Casser, Hadi
  • Migaud, Marie, E.

Abstract

Compositions are provided including nicotinic acid riboside ("NAR"), and derivatives thereof including l -(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)-nicotinic acid ("NAR triacetate" or "NARTA"); or derivatives of a reduced form of nicotinic acid riboside ("NARH"), including 1 - (2',3',5 '-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid ("NARH triacetate" or "NARJT-TA"); or derivatives of nicotinamide riboside ("NR"), including 1 -(2',3',5'-triacetyl- beta-D-ribofuranosyl)-nicotinamide ("NR triacetate" or "NRTA"); derivatives of a reduced form of nicotinamide riboside ("NRH"), including 1-(2',3 ',5'-triacetyl-beta-D-ribofuranosyl)- 1,4- dihydronicotinamide ("NRH triacetate" or "NRH-TA"); or salts or prodrugs thereof, for use in food or beverage applications, pharmaceutical formulations, or as a dietary supplement. Methods of using the compounds above to promote the increase of intracellular levels of nicotinamide adenine dinuc!eotide ("NAD+") or NADH in cells and tissues for improving cell and tissue survival or overall cell and tissue health are provided.

IPC Classes  ?

  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 31/7052 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
  • C07H 19/00 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radicalNucleosidesMononucleotidesAnhydro derivatives thereof
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom
  • C07H 19/048 - Pyridine radicals

63.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, NICOTINAMIDE MONONUCLEOTIDE, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA

      
Document Number 03021022
Status In Force
Filing Date 2017-04-14
Open to Public Date 2017-10-19
Grant Date 2024-04-23
Owner CHROMADEX INC. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abstract

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin Bl), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

IPC Classes  ?

  • A23L 33/15 - Vitamins
  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 7/06 - Heterocyclic radicals

64.

Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development

      
Application Number 15488215
Grant Number 10857172
Status In Force
Filing Date 2017-04-14
First Publication Date 2017-10-19
Grant Date 2020-12-08
Owner ChromaDex, Inc. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abstract

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

IPC Classes  ?

  • A61K 31/7064 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
  • A23L 33/00 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof
  • A23L 33/15 - Vitamins
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 31/51 - Thiamines, e.g. vitamin B1
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A61K 31/4415 - Pyridoxine, i.e.vitamin B6
  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • A61K 31/525 - Isoalloxazines, e.g. riboflavins, vitamin B2
  • A23L 33/19 - Dairy proteins
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61K 47/42 - ProteinsPolypeptidesDegradation products thereofDerivatives thereof, e.g. albumin, gelatin or zein

65.

USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, NICOTINAMIDE MONONUCLEOTIDE, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA

      
Application Number US2017027755
Publication Number 2017/181102
Status In Force
Filing Date 2017-04-14
Publication Date 2017-10-19
Owner CHROMADEX INC. (USA)
Inventor
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Morris, Mark
  • Conze, Dietrich
  • Boileau, Amy

Abstract

Methods for delivering at least one compound selected from nicotinamide riboside (NR), nicotinic acid riboside (NAR), and nicotinamide mononucleotide (NMN), derivatives thereof, or salts thereof, in combination with at least one of thiamine (vitamin Bl), riboflavin (vitamin B2), niacin (vitamin B3), and pyridoxine (vitamin B6), to an infant human subject in need of said compound or compounds are provided.

IPC Classes  ?

  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof
  • A61K 31/455 - Nicotinic acid, i.e. niacinDerivatives thereof, e.g. esters, amides
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 7/06 - Heterocyclic radicals
  • A23L 33/15 - Vitamins

66.

B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof

      
Application Number 15461126
Grant Number 10000520
Status In Force
Filing Date 2017-03-16
First Publication Date 2017-09-21
Grant Date 2018-06-19
Owner
  • ChromaDex Inc. (USA)
  • The Queen's University of Belfast (United Kingdom)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abstract

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): 8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

IPC Classes  ?

  • C07H 19/00 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radicalNucleosidesMononucleotidesAnhydro derivatives thereof
  • C07H 19/048 - Pyridine radicals
  • C07H 1/00 - Processes for the preparation of sugar derivatives
  • C07H 19/04 - Heterocyclic radicals containing only nitrogen as ring hetero atom

67.

B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF

      
Document Number 03017254
Status In Force
Filing Date 2017-03-16
Open to Public Date 2017-09-21
Grant Date 2023-08-22
Owner
  • THE QUEEN'S UNIVERSITY OF BELFAST (Ireland)
  • CHROMADEX INC. (USA)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abstract

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): wherein X-, Z1 Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

IPC Classes  ?

  • A61K 47/54 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
  • C07H 19/048 - Pyridine radicals

68.

B-VITAMIN AND AMINO ACID CONJUGATES OF NICOTINOYL RIBOSIDES AND REDUCED NICOTINOYL RIBOSIDES, DERIVATIVES THEREOF, AND METHODS OF PREPARATION THEREOF

      
Application Number US2017022779
Publication Number 2017/161165
Status In Force
Filing Date 2017-03-16
Publication Date 2017-09-21
Owner
  • CHROMADEX INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (United Kingdom)
Inventor
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Dellinger, Ryan
  • Rhonemus, Troy
  • Venkataraman, Sylesh
  • Nettles, Brian

Abstract

The present disclosure provides nicotinate/nicotinamide riboside compounds or derivatives of formula (I): wherein X-, Z1 Z2, n, R1, R2, R3, R4, R5, R6, R7, and R8 are described herein, reduced analogs thereof, and synthetic processes for the preparation thereof.

IPC Classes  ?

  • A01N 43/40 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof

69.

TRU NIAGEN

      
Serial Number 87982993
Status Registered
Filing Date 2017-06-21
Registration Date 2020-05-19
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 41 - Education, entertainment, sporting and cultural services
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

Providing information about fitness, exercise, and workouts; On-line journals, namely, blogs featuring articles, information, reviews and recipes in the field of health, fitness, exercise, workouts, wellness, lifestyle, healthy eating and nutrition Providing information about health, lifestyle wellness, healthy eating and nutrition

70.

TRU NIAGEN

      
Serial Number 87497901
Status Registered
Filing Date 2017-06-20
Registration Date 2018-01-02
Owner ChromaDex Inc. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Dietary and nutritional supplements

71.

NIAGEN

      
Application Number 1336169
Status Registered
Filing Date 2016-12-15
Registration Date 2016-12-15
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics. Dietary and nutritional supplements.

72.

NIAGEN

      
Application Number 181609500
Status Registered
Filing Date 2016-12-28
Registration Date 2018-12-18
Owner ChromaDex Inc. (USA)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Phytochemical additives for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics (2) Dietary and nutritional supplements for general health and well being

73.

SELECTIVE SOLVENT FREE PHOSPHORYLATION

      
Application Number US2016035729
Publication Number 2016/196941
Status In Force
Filing Date 2016-06-03
Publication Date 2016-12-08
Owner
  • CHROMADEX, INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (United Kingdom)
Inventor
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Crossey, Kerri
  • Cunningham, Richard
  • Rhonemus, Troy
  • Venkataraman, Sylesh

Abstract

A synthetic process is provided for the preparation of phosphorylated analogs of nicotinamide riboside ("NR") having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II), wherein X-, Y1, Y2, Z1, Z2, n, R1, R2, R3, R4, R5, R6, and R7 are as defined herein. The present disclosure also relates to the preparation of phosphorylated analogs of nicotinic acid riboside ("NAR") having the formula (I), or salts thereof, and reduced or modified derivatives thereof, having the formula (II). Generally solvent-free conditions are employed using appropriate mechano-chemical techniques as described. (I) (II)

IPC Classes  ?

  • A01N 43/40 - Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
  • A61K 31/44 - Non-condensed pyridinesHydrogenated derivatives thereof

74.

AGE BETTER

      
Application Number 180884300
Status Registered
Filing Date 2016-11-10
Registration Date 2018-07-30
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Nutraceuticals for use as a dietary supplement for general health and well-being; vitamin and mineral supplements; vitamins

75.

Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions

      
Application Number 15072121
Grant Number 10280190
Status In Force
Filing Date 2016-03-16
First Publication Date 2016-09-22
Grant Date 2019-05-07
Owner
  • ChromaDex, Inc. (USA)
  • The Queen's University of Belfast (Ireland)
Inventor
  • Dellinger, Ryan
  • Migaud, Marie Eugenie
  • Redpath, Philip
  • Rhonemus, Troy
  • Cunningham, Richard

Abstract

Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2′,3′,5′-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.

IPC Classes  ?

76.

NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE COMPOSITIONS, REDUCED DERIVATIVES THEREOF, AND THE USE THEREOF

      
Document Number 02979057
Status In Force
Filing Date 2016-03-16
Open to Public Date 2016-09-22
Grant Date 2023-01-24
Owner
  • CHROMADEX INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (United Kingdom)
Inventor
  • Dellinger, Ryan
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Rhonemus, Troy
  • Cunningham, Richard

Abstract

Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2', 3', 5'-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2',3',5'-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • C07H 19/048 - Pyridine radicals

77.

NICOTINIC ACID RIBOSIDE OR NICOTINAMIDE RIBOSIDE COMPOSITIONS, REDUCED DERIVATIVES THEREOF, AND THE USE THEREOF

      
Application Number US2016022682
Publication Number 2016/149395
Status In Force
Filing Date 2016-03-16
Publication Date 2016-09-22
Owner
  • CHROMADEX INC. (USA)
  • THE QUEEN'S UNIVERSITY OF BELFAST (United Kingdom)
Inventor
  • Dellinger, Ryan
  • Migaud, Marie, Eugenie
  • Redpath, Philip
  • Rhonemus, Troy
  • Cunningham, Richard

Abstract

Derivatives of nicotinic acid riboside (NAR), nicotinamide riboside (NR), and reduced NAR and NR, including 1-(2', 3', 5'-triacetyl-beta-D-ribofuranosyl)-1,4-dihydronicotinic acid (4a), and compositions containing the same and/or reduced derivative forms of nicotinamide riboside including 1-(2',3',5'-triacetyl-beta-D-ribofuranosyl)-1,4-nicotinamide (2), are provided for use in the care of treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing one or more NR, NAR, NRH, or NARH derivatives, or prodrugs or salts thereof. In further embodiments, the invention relates to methods of using one or more NR, NAR, NRH, or NARH derivatives, or prodrugs, solvates, or salts thereof, to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival and overall cell and tissue health.

IPC Classes  ?

  • C07H 19/048 - Pyridine radicals
  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom

78.

Nicotinamide riboside compositions for topical use in treating skin conditions

      
Application Number 15033285
Grant Number 10688118
Status In Force
Filing Date 2014-10-30
First Publication Date 2016-09-01
Grant Date 2020-06-23
Owner ChromaDex Inc. (USA)
Inventor
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abstract

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom

79.

AGE BETTER

      
Serial Number 87036537
Status Registered
Filing Date 2016-05-13
Registration Date 2017-05-09
Owner CHROMADEX, INC. ()
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Nutraceuticals for use as a dietary supplement; Vitamin and mineral supplements; Vitamins

80.

NIAGEN

      
Application Number 014042428
Status Registered
Filing Date 2015-05-09
Registration Date 2017-11-02
Owner ChromaDex, Inc. (USA)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Dietary supplements and dietetic preparations; Medical and veterinary preparations and articles; Nutritional supplements.

81.

NICOTINAMIDE RIBOSIDE COMPOSITIONS FOR TOPICAL USE IN TREATING SKIN CONDITIONS

      
Application Number US2014063260
Publication Number 2015/066382
Status In Force
Filing Date 2014-10-30
Publication Date 2015-05-07
Owner CHROMADEX INC. (USA)
Inventor
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abstract

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

IPC Classes  ?

82.

NICOTINAMIDE RIBOSIDE COMPOSITIONS FOR TOPICAL USE IN TREATING SKIN CONDITIONS

      
Document Number 02928656
Status In Force
Filing Date 2014-10-30
Open to Public Date 2015-05-07
Grant Date 2020-07-28
Owner CHROMADEX INC. (USA)
Inventor
  • Deren-Lewis, Ann
  • Rhonemus, Troy

Abstract

Compositions containing nicotinamide riboside (NR) are provided. NR containing compositions are used in the care or treatment of skin and skin conditions. In some embodiments, the invention relates to pharmaceutical compositions and cosmetic compositions containing nicotinamide riboside. In further embodiments, the invention relates to methods of using nicotinamide riboside to promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival. A method of treating signs or symptoms of aging or skin wrinkles in an individual is provided, comprising topically administering to the individual in need of such treatment an effective amount of the compound nicotinamide riboside, or salts thereof.

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
  • A61P 17/16 - Emollients or protectives, e.g. against radiation
  • A61Q 17/04 - Topical preparations for affording protection against sunlight or other radiationTopical sun tanning preparations
  • C07H 19/048 - Pyridine radicals

83.

IMMULINA

      
Serial Number 86616799
Status Registered
Filing Date 2015-05-01
Registration Date 2019-03-12
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Chemical reagents for non-medical purposes; Chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes Dietary and nutritional supplements

84.

C

      
Serial Number 86588333
Status Registered
Filing Date 2015-04-06
Registration Date 2015-11-17
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Chemical reagents for non-medical purposes; Chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes Dietary and nutritional supplements Innovation consulting services, namely, advising others in the areas of product development; Product development consulting in the field of dietary supplements, nutritional products, pharmaceuticals and cosmetics; Scientific consulting and research services relating to foods and dietary supplements; Chemical, biochemical, biological and bacteriological research and analysis; Consulting in the field of product development in the field of chemicals; Development and establishment of testing specifications and procedures in the field of chemicals; Development and test of chemical production methods; Development of voluntary standards for chemicals; Executing of chemical analyses; Industrial research in the field of chemicals; Pharmaceutical research and development; Product research and development; Research and development and consultation related thereto in the field of chemicals; Testing of raw materials

85.

METHOD FOR INDUCING UDP-GLUCURONOSYLTRANSFERASE ACTIVITY USING PTEROSTILBENE

      
Application Number US2012064993
Publication Number 2013/169291
Status In Force
Filing Date 2012-11-14
Publication Date 2013-11-14
Owner
  • CHROMADEX INC. (USA)
  • THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (USA)
Inventor
  • Bartos, Jeremy
  • Dellinger, Ryan

Abstract

A method is provided for treating an individual for a cellular proliferative disorder, including administering to the individual in need of such treatment a therapeutically effective amount of the compound pterostilbene wherein UDP-glucuronosyltransferase (UGT) activity is increased. In an embodiment, 12-HETE levels can be reduced by administration of pterostilbene.

IPC Classes  ?

86.

PTEROSTILBENE AND CURCUMIN COMBINATION FOR TREATMENT OF OXIDATIVE STRESS AND INFLAMMATION

      
Application Number US2013039105
Publication Number 2013/166177
Status In Force
Filing Date 2013-05-01
Publication Date 2013-11-07
Owner CHROMADEX INC. (USA)
Inventor Bartos, Jeremy

Abstract

A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of curcumin, and a pharmaceutically acceptable carrier. The embodiments of the pharmaceutical compositions can have lipid lowering properties, or alternatively can have properties that can treat oxidative stress, by decreasing inflammation or inflammatory processes contributing to digestive disorders or cancer. A method of treating an individual for an inflammatory disorder is provided, comprising administering to the individual in need of such treatment a pharmaceutical composition including a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a curcumin, and a pharmaceutically acceptable carrier. The combination containing pterostilbene and curcumin is effective for treatment or prevention of oxidative stress, treatment of digestive disorders including inflammatory bowel disease, and/or to reduce or inhibit inflammation, in both animals and in humans.

IPC Classes  ?

  • A61K 31/09 - Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
  • A61K 31/12 - Ketones

87.

PTEROSTILBENE AND PVP GRAPE JUICE EXTRACT COMBINATION FOR TREATMENT OF METABOLIC, VASCULAR, AND NEURODEGENERATIVE DISORDERS

      
Application Number US2012069485
Publication Number 2013/090557
Status In Force
Filing Date 2012-12-13
Publication Date 2013-06-20
Owner
  • CHROMADEX INC. (USA)
  • CLIFFSTAR LLC (USA)
Inventor
  • Bartos, Jeremy
  • Lynch, Douglas

Abstract

A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a polyphenolic-PVP extract of grape juice, and a pharmaceutically acceptable carrier. The embodiments of the pharmaceutical compositions can have lipid lowering properties, or alternatively can have properties that can treat oxidative stress, by decreasing inflammation or inflammatory processes contributing to neurodegenerative diseases. A method of lowering lipid levels in an individual is also provided, comprising administering to the individual in need of such treatment a pharmaceutical composition including a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a polyphenolic-PVP extract of grape juice, and a pharmaceutically acceptable carrier, wherein lipid levels are decreased.

IPC Classes  ?

  • A61K 31/05 - Phenols
  • A61K 36/87 - Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine

88.

NIAGEN

      
Serial Number 85932490
Status Registered
Filing Date 2013-05-15
Registration Date 2014-09-16
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products [, pharmaceuticals and cosmetics ] Dietary and nutritional supplements

89.

PTEROSTILBENE AND STATIN COMBINATION FOR TREATMENT OF METABOLIC DISEASE, CARDIOVASCULAR DISEASE, AND INFLAMMATION

      
Application Number US2012055784
Publication Number 2013/040574
Status In Force
Filing Date 2012-09-17
Publication Date 2013-03-21
Owner CHROMADEX INC. (USA)
Inventor Bartos, Jeremy

Abstract

A pharmaceutical composition is provided comprising a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a statin compound, and a pharmaceutically acceptable carrier. The embodiments of the pharmaceutical compositions can have lipid lowering properties, or alternatively can have properties that can treat oxidative stress, by decreasing inflammation or inflammatory processes contributing to neurodegenerative diseases. A method of lowering lipid levels in an individual is also provided, comprising administering to the individual in need of such treatment a pharmaceutical composition including a therapeutically effective amount of pterostilbene, a therapeutically effective amount of a statin compound, and a pharmaceutically acceptable carrier, wherein lipid levels are decreased.

IPC Classes  ?

  • A61K 38/00 - Medicinal preparations containing peptides

90.

PURENERGY

      
Serial Number 85857505
Status Registered
Filing Date 2013-02-22
Registration Date 2014-04-08
Owner ChromaDex Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, * and * pharmaceuticals [ and cosmetics ]

91.

PTEROGOLD

      
Serial Number 85502196
Status Pending
Filing Date 2011-12-22
Owner ChromaDex Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements, nutritional products, pharmaceuticals and cosmetics

92.

CHROMADEX

      
Application Number 1075641
Status Registered
Filing Date 2011-03-24
Registration Date 2011-03-24
Owner ChromaDex, Inc. (USA)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical reagents for non-medical purposes; chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; chemicals for use in industry and science; chemicals for use in the biochemical and chemical industry; assays for research purposes. Chemical, biochemical, biological and bacteriological research and analysis; consulting in the field of product development in the field of chemicals; development and establishment of testing specifications and procedures in the field of chemicals; development and test of chemical production methods; development of voluntary standards for chemicals; executing of chemical analyses; industrial research in the field of chemicals; pharmaceutical research and development; Product research and development; Research and development and consultation related thereto in the field of chemicals; testing of raw materials.

93.

PTEROPURE

      
Serial Number 77939875
Status Registered
Filing Date 2010-02-19
Registration Date 2011-03-15
Owner ChromaDex Inc. ()
NICE Classes  ? 01 - Chemical and biological materials for industrial, scientific and agricultural use

Goods & Services

Phytochemicals for use in the manufacturing of dietary supplements and nutritional products

94.

CHROMADEX

      
Serial Number 77939870
Status Registered
Filing Date 2010-02-19
Registration Date 2011-07-19
Owner ChromaDex Inc. ()
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

[ Chemical reagents for non-medical purposes; ] Chemical test kits for analytical measurement of raw material identity, potency and formulation consistency for laboratory or research use; Chemicals for use in industry and science; Chemicals for use in the biochemical and chemical industry; Assays for research purposes Chemical, biochemical, biological and bacteriological research and analysis; Consulting in the field of product development in the field of chemicals; Development and establishment of testing specifications and procedures in the field of chemicals; Development and test of chemical production methods; Development of voluntary standards for chemicals; Executing of chemical analyses; [ Industrial research in the field of chemicals; ] Pharmaceutical research and development; Product research and development; Research and development and consultation related thereto in the field of chemicals; Testing of raw materials